Literature DB >> 18291715

Analysis of the full-length genome of hepatitis B virus in the serum and cerebrospinal fluid of a patient with acute hepatitis B and transverse myelitis.

Jun Inoue1, Yoshiyuki Ueno, Takayuki Kogure, Futoshi Nagasaki, Osamu Kimura, Noriyuki Obara, Osamu Kido, Yu Nakagome, Eiji Kakazu, Yasunori Matsuda, Koji Fukushima, Haruna Segawa, Ichiro Nakajima, Yasuto Itoyama, Masaharu Takahashi, Hiroaki Okamoto, Tooru Shimosegawa.   

Abstract

Although many extrahepatic manifestations have been described in patients with acute or chronic hepatitis B, there are few reports about neurological disorders. We describe a 55-year-old man who contracted acute hepatitis B virus (HBV) infection and transverse myelitis. His neurological findings were gradually reduced along with the recovery from hepatitis. The cerebrospinal fluid (CSF) was revealed to be positive for HBsAg and HBV DNA. Full-length sequences of HBV in his serum and CSF were determined, and it was revealed that these two isolates had mutations at nucleotide (nt) 1762/1764 in the core promoter region and nt 1896 in the precore region. They were identical to each other except for two ambiguous codes at nt 2020 and 2631 in the CSF isolate. After cloning of the amplicons, substitutions at nt 2020 and 2631 were found in 6 (38%) of the 16 CSF clones. One clone of the 6 CSF clones had an additional substitution at nt 2119. These substitutions were not found in 16 serum clones. The presence of HBV clones unique to CSF suggests that HBV was a possible causative agent of the myelitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18291715     DOI: 10.1016/j.jcv.2008.01.002

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  5 in total

1.  Reactivation of resolved hepatitis B virus infection with immune escape mutations after long-term corticosteroid therapy.

Authors:  Jun Inoue; Yasuteru Kondo; Yuta Wakui; Takayuki Kogure; Tatsuki Morosawa; Yasuyuki Fujisaka; Teruyuki Umetsu; Satoshi Takai; Takuya Nakamura; Tooru Shimosegawa
Journal:  Clin J Gastroenterol       Date:  2016-02-26

2.  Hepatitis B virus compartmentalization in the cerebrospinal fluid of HIV-infected patients.

Authors:  L Ene; D Duiculescu; G Tardei; S Ruta; D M Smith; S Mehta; S Letendre; C L Achim
Journal:  Clin Microbiol Infect       Date:  2014-11-23       Impact factor: 8.067

3.  Anti-CASPR2 myeloencephalitis with active replication of hepatitis B virus in the central nervous system: a case report.

Authors:  Xu Liu; Lu Wang; Di Zhong; Bo Yan; Xiaoting Hao
Journal:  Acta Neurol Belg       Date:  2022-04-12       Impact factor: 2.471

4.  Contribution of quantitative viral markers to document hepatitis B virus compartmentalization in cerebrospinal fluid during hepatitis B with neuropathies.

Authors:  Charlotte Pronier; Dominique Guyader; Caroline Jézequel; Pierre Tattevin; Vincent Thibault
Journal:  J Neurovirol       Date:  2018-08-10       Impact factor: 2.643

5.  Meta-transcriptomic identification of hepatitis B virus in cerebrospinal fluid in patients with central nervous system disease.

Authors:  John H-O Pettersson; Geraldine Piorkowski; Mayfong Mayxay; Sayaphet Rattanavong; Manivanh Vongsouvath; Viengmon Davong; Kristian Alfsnes; Vegard Eldholm; Xavier de Lamballerie; Edward C Holmes; Paul N Newton; Audrey Dubot-Pérès
Journal:  Diagn Microbiol Infect Dis       Date:  2019-08-01       Impact factor: 2.803

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.